1. Home
  2. PRPO vs NVOS Comparison

PRPO vs NVOS Comparison

Compare PRPO & NVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRPO
  • NVOS
  • Stock Information
  • Founded
  • PRPO N/A
  • NVOS 2000
  • Country
  • PRPO United States
  • NVOS United States
  • Employees
  • PRPO N/A
  • NVOS N/A
  • Industry
  • PRPO Biotechnology: Laboratory Analytical Instruments
  • NVOS Assisted Living Services
  • Sector
  • PRPO Industrials
  • NVOS Health Care
  • Exchange
  • PRPO Nasdaq
  • NVOS Nasdaq
  • Market Cap
  • PRPO 8.8M
  • NVOS 9.9M
  • IPO Year
  • PRPO N/A
  • NVOS 2017
  • Fundamental
  • Price
  • PRPO $5.08
  • NVOS $0.67
  • Analyst Decision
  • PRPO
  • NVOS
  • Analyst Count
  • PRPO 0
  • NVOS 0
  • Target Price
  • PRPO N/A
  • NVOS N/A
  • AVG Volume (30 Days)
  • PRPO 9.8K
  • NVOS 1.9M
  • Earning Date
  • PRPO 08-15-2024
  • NVOS 07-19-2024
  • Dividend Yield
  • PRPO N/A
  • NVOS N/A
  • EPS Growth
  • PRPO N/A
  • NVOS N/A
  • EPS
  • PRPO N/A
  • NVOS N/A
  • Revenue
  • PRPO $15,812,000.00
  • NVOS $13,516,958.00
  • Revenue This Year
  • PRPO $75.18
  • NVOS N/A
  • Revenue Next Year
  • PRPO N/A
  • NVOS N/A
  • P/E Ratio
  • PRPO N/A
  • NVOS N/A
  • Revenue Growth
  • PRPO 61.64
  • NVOS 1102.98
  • 52 Week Low
  • PRPO $4.31
  • NVOS $0.42
  • 52 Week High
  • PRPO $8.99
  • NVOS $5.38
  • Technical
  • Relative Strength Index (RSI)
  • PRPO 48.60
  • NVOS 48.99
  • Support Level
  • PRPO $4.32
  • NVOS $0.51
  • Resistance Level
  • PRPO $5.80
  • NVOS $0.58
  • Average True Range (ATR)
  • PRPO 0.43
  • NVOS 0.07
  • MACD
  • PRPO 0.06
  • NVOS -0.01
  • Stochastic Oscillator
  • PRPO 51.68
  • NVOS 63.38

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

About NVOS Novo Integrated Sciences Inc.

Novo Integrated Sciences Inc is a medical care company. It provides specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, neurological functions, kinesiology, and others. It has two reportable segments: healthcare services which generates majority of the revenue, and product sales.

Share on Social Networks: